Recently introduced Pixxoscan (Gadobutrol), our macrocyclic, non-ionic gadolinium-based contrast agent (GBCA). This expands our portfolio of Magnetic Resonance Imaging (MRI) contrast agents, with two leading macrocyclic molecules - Clariscan™ (gadoteric acid) and now Pixxoscan (gadobutrol).
Pixxoscan is authorised in Austria, Norway, Spain and France (as Pixcyclic) and is not available in all of Europe. In the UK, Pixxoscan is known as Gadobutrol.
For full prescribing information on Gadobutrol in the UK,
click here.
For full prescribing information on Clariscan in the UK
click here
Adverse events should be reported.
Reporting forms and information can be found at:
yellowcard.mhra.gov.uk
Adverse events should also be reported to GE HealthCare at:
gpv.drugsafety@gehealthcare.com